SCHEMBL21691647

SCHEMBL21691647

N#Cc1ccc2sc3c(-c4cc(-c5ccccc5C#N)cc(-c5cccc6c5sc5ccccc56)c4)cccc3c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
PARP14 Q460N5 1/20 0.36
GABRG2 P18507 6/20 0.35
GABRB3 P28472 6/20 0.35
GABRA1 P14867 5/20 0.35
GABRA2 P47869 4/20 0.35
ESR2 Q92731 1/20 0.35
AR P10275 1/20 0.35
G6PD P11413 1/20 0.34
CCNB2 O95067 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3B P49841 1/20 0.34
CCNA1 P78396 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
PRKDC P78527 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21692331 0.97 ALOX5 (0.42) ALOX5GABRG2GABRB3GABRA1GABRA2
SCHEMBL21692589 0.94 ALOX5 (0.44) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21692576 0.94 ALOX5 (0.44) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21692402 0.92 ALOX5 (0.43) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21691783 0.92 ALOX5 (0.39) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21693173 0.92 ALOX5 (0.39) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21691789 0.92 ALOX5 (0.42) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21692584 0.92 ALOX5 (0.41) ALOX5GABRG2GABRB3GABRA1GABRA2
SCHEMBL21692481 0.91 ALOX5 (0.49) ALOX5PARP14GABRG2GABRB3GABRA1
SCHEMBL21693065 0.91 ALOX5 (0.54) ALOX5PARP14GABRG2GABRB3GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885PARP14 1715/4885GABRG2 4389/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885PARP14 1715/4885GABRG2 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.